Sunday, September 20, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 16, 2026

Smart Home Healthcare Market Outlook 2025-2033: Analysis of Growth Drivers, Constraints, Opportunities, and Trends | Astute Analytica

View original at globenewswire.com
Smart Home Healthcare Market Outlook 2025-2033: Analysis of Growth Drivers, Constraints, Opportunities, and Trends | Astute Analytica Chicago, Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The growth of the smart home healthcare market is strongly influenced by the increasing number of aging individuals who prioritize maintaining independence while managing their health

    80% confidence
  • Approximately 48.9 million households in the United States currently utilize at least one connected health device

    80% confidence
  • The global smart home healthcare market was valued at US$ 27.46 billion in 2024 and is estimated to surpass a market size of US$ 194.51 billion by 2033 at a CAGR of 24.3% during the forecast period 2025–2033

    80% confidence
  • The growing prevalence of chronic diseases is a major catalyst driving the expansion of the smart home healthcare market

    80% confidence
  • Global shipment volume of wearable health devices reached 487 million in 2024

    80% confidence
  • Testing, screening, and monitoring products captured a commanding 76.90% share of revenue in the smart home healthcare market in 2024

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com
Smart Home Healthcare Market Outlook 2025-2033: Analysis of Growth Drivers, Constraints, Opportunities, and Trends | Astute Analytica — Source | Via News | Via News